Assist. Prof. Dr. Keyang Xu | Macau University of Science and Technology | China
🎓 Dr. Keyang Xu is an Assistant Professor at the Faculty of Chinese Medicine, Macau University of Science and Technology. His research explores the intersections of oncology and metabolism, focusing on exosomes, proteomics, noncoding RNA, and natural therapies. With extensive experience from prestigious institutions like Hong Kong Baptist University and the University of Sydney, Dr. Xu is dedicated to advancing cancer research and translational medicine. He actively contributes as an editor for Frontiers in Oncology and the Journal of Taibah University for Science, driving scientific innovation in his field.
Professional Profile:
ORCID
Suitability for Best Researcher Award
Dr. Keyang Xu is an exceptional candidate for the Best Researcher Award, given his pioneering contributions to oncology and metabolism. As an Assistant Professor at the Faculty of Chinese Medicine, Macau University of Science and Technology, Dr. Xu explores cutting-edge areas including exosomes, proteomics, noncoding RNA, and natural therapies, which are at the forefront of cancer research and translational medicine. His interdisciplinary approach bridges traditional Chinese medicine with modern biomedical science, paving the way for innovative cancer therapies.
Education & Experience:
- 🎓 Ph.D. in Chinese Medicine – Hong Kong Baptist University (2021-2024)
- 🎓 Visitor Scholar – Storr Liver Center, University of Sydney (2024)
- 🎓 Master’s Degree – Chinese & Western Clinical Medicine, Zhejiang Chinese Medical University (2016-2019)
- 🎓 Medicine Degree – Chengdu University of Traditional Chinese Medicine (2011-2016)
- 🧑🏫 Assistant Professor – Macau University of Science and Technology (2025-Present)
- 🔬 Research Assistant – Hong Kong Baptist University (2020-2024)
- 🩺 Physician – Lvkang Geriatric Rehabilitation Hospital, Hangzhou (2019-2020)
- 🩺 Physician – Xiwenbeiyuan Clinic, Hangzhou (2018-2019)
Professional Development:
🌏 Global Collaborations – Dr. Xu has collaborated internationally, including with renowned experts at the Storr Liver Center in Sydney.
📚 Editorial Roles – He actively contributes to scientific literature as an editor for Frontiers in Oncology and the Journal of Taibah University for Science.
🎓 Mentorship & Teaching – As an Assistant Professor, he guides future researchers and medical professionals.
🔬 Innovative Research – His research delves into the roles of exosomes, proteomics, noncoding RNA, and natural therapies in oncology and metabolism.
🤝 Professional Memberships – Active in the Good Practice in Traditional Chinese Medicine Research Association and Student Networks on EVs, fostering a collaborative scientific community.
Research Focus:
🧬 Oncology & Metabolism – Investigating the mechanisms linking cancer and metabolic disorders.
📦 Exosomes – Exploring the role of adipose tissue-derived exosomes in cancer metastasis and metabolic regulation.
🧪 Proteomics – Utilizing omics approaches to understand protein profiles influenced by obesity and metabolic changes.
🧬 Noncoding RNA – Investigating lncRNAs’ role in cancer progression and recurrence, particularly in HBV-related hepatocellular carcinoma.
🌿 Natural Therapy – Examining the therapeutic effects of natural compounds like Resveratrol on metabolic diseases and cancer.
Awards & Honors:
- 🏅 Research Grant – High-fat diet-enhanced colorectal cancer metastasis project (RC-FNRA-IG/20-21/SCM/01)
- 🏅 Research Grant – Effects of obesity on exosomal protein profiles (#2021Szvup131)
- 🏅 Research Grant – Molecular mechanism of LncBRM in HBV-related hepatocellular carcinoma (LSY19H030002)
- 🏅 Research Grant – Treating hyperuricemia-related NAFLD with Resveratrol (2014ZA090)
- 🏅 Research Grant – Clinical value of CHI3L1 in chronic hepatitis B (2019KY532)
Publication Top Notes:
-
“An Integration of RNA Sequencing and Network Pharmacology Approaches Predicts the Molecular Mechanisms of the Huo-Xue-Shen Formula in the Treatment of Liver Fibrosis” – 🧬📊
-
“Exosomes in Skin Flap Survival: Unlocking Their Role in Angiogenesis and Tissue Regeneration” – 🧫🩺
-
“Shared Genetic Links Between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease” – 🧬❤️
-
“Exploring Tumor Heterogeneity in Colorectal Liver Metastases by Imaging: Unsupervised Machine Learning of Preoperative CT Radiomics Features for Prognostic Stratification” – 🧠🤖
-
“Elevated Extracellular Matrix Protein 1 in Circulating Extracellular Vesicles Supports Breast Cancer Progression Under Obesity Conditions” – 🧬⚖️
-
“Untimely Surgery for Stent-Fracture-Related Death After Transjugular Intrahepatic Portosystemic Shunt: A Case Report” – 🩺📄
-
“Brevilin A is a Potent Anti-Metastatic CRC Agent That Targets the VEGF-IL6-STAT3 Axis in the HSCs-CRC Interplay” – 🧬🛡️